KalVista Pharmaceuticals
KALV
#6279
Rank
C$0.89 B
Marketcap
$18.00
Share price
0.85%
Change (1 day)
25.61%
Change (1 year)

Earnings for KalVista Pharmaceuticals (KALV)

Earnings in 2025 (TTM): -C$0.24 Billion

According to KalVista Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$0.24 Billion a decrease over its 2023 earnings that were of -C$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for KalVista Pharmaceuticals from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.24 Billion0.89%
2024 -C$0.24 Billion43.36%
2023 -C$0.17 Billion12.87%
2022 -C$0.15 Billion20.62%
2021 -C$0.13 Billion79.87%
2020 -C$67.67 Million14.01%
2019 -C$59.35 Million98.95%
2018 -C$29.83 Million3.41%
2017 -C$28.85 Million-13.11%
2016 -C$33.21 Million1.3%
2015 -C$32.78 Million92.7%
2014 -C$17.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.2 Billion-16.65%๐Ÿ‡บ๐Ÿ‡ธ USA